Results 71 to 80 of about 1,309,096 (135)

Cardiomyopathy: pathogenesis and therapeutic interventions

open access: yesMedComm, Volume 5, Issue 11, November 2024.
Cardiomyopathy is a group of diseases characterized by structural and functional damage to the myocardium. Many specific gene mutations, environmental factors, and metabolic disorders may cause cardiomyopathy. Traditional therapeutic includes drug and surgery. With the growing comprehension of the molecular mechanisms underlying cardiomyopathy.
Shitong Huang   +9 more
wiley   +1 more source

Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells

open access: yesMicrobial Cell, 2018
Cardiolipin (CL) optimizes diverse mitochondrial processes, including oxidative phosphorylation (OXPHOS). To function properly, CL needs to be unsaturated, which requires the acyltransferase Tafazzin (TAZ).
Maxence de Taffin de Tilques   +10 more
doaj   +1 more source

Advances in cardiac tissue engineering and heart‐on‐a‐chip

open access: yesJournal of Biomedical Materials Research Part A, Volume 112, Issue 4, Page 492-511, April 2024.
Abstract Recent advances in both cardiac tissue engineering and hearts‐on‐a‐chip are grounded in new biomaterial development as well as the employment of innovative fabrication techniques that enable precise control of the mechanical, electrical, and structural properties of the cardiac tissues being modelled.
Jennifer Kieda   +9 more
wiley   +1 more source

Metabolic alterations in a murine model of Barth syndrome [PDF]

open access: yes, 2018
Barth syndrome (BTHS) is a rare monogenic disease characterized by cardiomyopathy, skeletal myopathy and neutropenia, caused by mutations in the Xq28 locus.
Laprano, Nicola
core   +1 more source

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

open access: yes, 2022
Cardiolipin (CL), a dimeric phospholipid carrying four fatty acid chains in its structure, is the lipid marker of mitochondria, wherein it plays a crucial role in the functioning of the inner membrane.
Lobasso S.   +7 more
core   +1 more source

Biochemical Characterization Of Induced Pluripotent Stem Cell-Derived Cardiomyocytes As A Model Of Barth Syndrome [PDF]

open access: yes, 2022
Barth Syndrome (BTHS) is an X-linked inborn error of metabolism (IEM) which manifests as a multi-systemic disease. One of the primary symptoms is dilated cardiomyopathy, and alongside the cardiovascular disease that arises, patients often experience ...
House, Alisha J
core  

The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies [PDF]

open access: yes, 1997
Barth syndrome (BTHS) is an X-linked disorder characterized clinically by the associated features of cardiac and skeletal myopathy, short stature, and neutropenia.
Barth, P.   +37 more
core   +1 more source

Barth syndrome (BTHS) – report case [PDF]

open access: yesChild Neurology, 2015
Joanna Pelc   +2 more
openaire   +1 more source

Understanding the life experience of Barth syndrome from the perspective of adults: a qualitative one-on-one interview study

open access: yesOrphanet Journal of Rare Diseases, 2019
Background Barth syndrome (BTHS, OMIM 302060) is a rare, life-threatening, x-linked genetic disorder that occurs almost exclusively in males and is characterized by cardiomyopathy, neutropenia, skeletal muscle myopathy primarily affecting larger muscles,
Iyar Mazar   +7 more
doaj   +1 more source

Functional exercise capacity, strength, balance and motion reaction time in Barth syndrome

open access: yesOrphanet Journal of Rare Diseases, 2019
Background Barth syndrome (BTHS) is an X-linked disorder caused by defects in TAZ with key clinical features including cardiomyopathy, neutropenia and skeletal myopathy.
Brittany Hornby   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy